Molecular markers of metastatic disease in KRAS-mutant lung adenocarcinoma is a research paper published in Annals of Oncology (2023). On theSindex it has a DataRank of 0.510. It has been cited 29 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.510
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →American Cancer Society
Grant: CRP-17-111-01-CDD
National Cancer Institute
Grant: R35CA220497
National Cancer Institute
Grant: U01CA213273
National Cancer Institute
Grant: RO1CA190294
NCI NIH HHS
Grant: R01 CA190394
NCI NIH HHS
Grant: R01 CA203636
NCI NIH HHS
Grant: R01 CA227388
NCI NIH HHS
Grant: P50 CA265826
NCI NIH HHS
Grant: P50 CA070907
NCI NIH HHS
Grant: U01 CA209414
NCI NIH HHS
Grant: T32 CA009172
Dana-Farber Cancer Institute
Rexanna's Foundation
Conquer Cancer Foundation
Ludwig Center at Harvard
The Mark Foundation for Cancer Research
SITC
FWCI
3.29
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals